Rats | Modality/tracer | Duration (min) | Injection 1 (T = 0 min) | Injection 2 | Injection 3 | ||||
---|---|---|---|---|---|---|---|---|---|
SA†(GBq/μmol) | J1* (MBq/μg) | Time (min) | J2* (MBq/μg) | J2 (μg) | Time (min) | J3 (μg) | |||
1 | TLC/[123I]epidepride | 180 | > 1000 | 89.6/< 0.05 | – | – | – | – | – |
2 | TLC/[123I]epidepride | 180 | > 1000 | 98.2/< 0.05 | – | – | – | – | – |
3 | TLC/[123I]epidepride | 180 | > 1000 | 96.9/< 0.05 | – | – | – | – | – |
4 | TLC/[123I]epidepride | 180 | > 1000 | 77.4/< 0.05 | – | – | – | – | – |
5 | SPECT-MI/[123I]epidepride | 360 | 1065.86 | 95.4/0.043 | 180 | 103.4/0.047 | 1.07 | 240 | 214.00 |
6 | SPECT-MI/[123I]epidepride | 360 | 967.71 | 87.4/0.043 | 180 | 93.5/0.046 | 2.35 | 240 | 234.50 |
7 | SPECT-MI/[123I]epidepride | 360 | 955.45 | 87.6/0.044 | 180 | 97.5/0.049 | 1.10 | 240 | 221.00 |
8 | SPECT-PSA/[123I]epidepride | 180 | 19.50 | 52.7/1.30 | – | – | – | – | – |
9 | SPECT-PSA/[123I]epidepride | 180 | 23.74 | 58.6/1.19 | – | – | – | – | – |
10 | SPECT-PSA/[123I]epidepride | 180 | 40.67 | 113.06/1.34 | – | – | – | – | – |
11 | SPECT-PSA/[123I]epidepride | 180 | 29.51 | 75.24/1.23 | – | – | – | – | – |
12 | SPECT-PSA_CON/[123I]epidepride | 180 | 18.85 | 49.35/1.26 | – | – | – | – | – |
13 | SPECT-PSA_CON/[123I]epidepride | 180 | 16.98 | 43.48/1.23 | – | – | – | – | – |
14 | SPECT-PSA_CON/[123I]epidepride | 180 | 22.74 | 45.65/0.97 | – | – | – | – | – |
15 | SPECT-PSA_CON/[123I]epidepride | 180 | 17.10 | 41.15/1.16 | – | – | – | – | – |
16 | SPECT-PSA_HAL/[123I]epidepride | 180 | 18.81 | 46.09/1.18 | – | – | – | – | – |
17 | SPECT-PSA_HAL/[123I]epidepride | 180 | 16.72 | 40.7/1.17 | – | – | – | – | – |
18 | SPECT-PSA_HAL/[123I]epidepride | 180 | 16.95 | 38.47/1.09 | – | – | – | – | – |